Battle of the scopes: which technique best wipes out Barrett's lesions?
NCT ID NCT05276791
First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time
Summary
This trial compares two endoscopic procedures—endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD)—for removing visible precancerous lesions in people with Barrett's esophagus. About 331 adults with Barrett's esophagus and early-stage abnormal tissue will be randomly assigned to one of the two techniques. The goal is to see which method more completely removes the lesions and prevents them from coming back within a year, without using ablation therapy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD)
- What this could lead to
- If one technique proves superior, it could become the standard approach for removing early-stage lesions in Barrett's esophagus, reducing the risk of cancer progression.
- What could go wrong
- This is a single trial with 331 participants, and results may not apply to all patients. ESD is more complex and carries a higher risk of complications like bleeding or perforation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BARRETT ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Amsterdam University Medical Center
RECRUITINGAmsterdam, Netherlands
-
Catharina Ziekenhuis
RECRUITINGEindhoven, Netherlands
-
Erasmus Medical Center
RECRUITINGRotterdam, Netherlands
-
St. Antonius Ziekenhuis
RECRUITINGNieuwegein, Netherlands
-
University Medical Center Groningen
RECRUITINGGroningen, Netherlands
-
University Medical Center Utrecht
RECRUITINGUtrecht, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- A high-tech camera may take the guesswork out of spotting a dangerous surgery complication
- Blood test score may flag High-Risk esophageal surgery patients
- Can surgery for stomach or esophageal cancer cloud the mind?
- Virtual patients could revolutionize cancer drug testing
- Can a pill restore the Body's tumor suppressor to fight multiple cancers?